Evidence map›Paper›PMID 30937404›Full record

ArticleParasite epidemiology and control2019

The epidemiology of cutaneous leishmaniasis in Golestan Province, Iran: A cross-sectional study of 8-years.

Oghlniaz Jorjani, Kamal Mirkarimi, Abdurrahman Charkazi, Yousef Dadban Shahamat, Zahra Mehrbakhsh, Ali Bagheri

Abstract read
In one paragraph

Article in Parasite epidemiology and control, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oghlniaz JorjaniLaboratory Science Research Center, Department of Medical Laboratory Science, Faculty of Paramedicine, Golestan University of Medical Sciences, Gorgan, Iran.
Kamal MirkarimiHealth Management and Social Development Research Center, Department of Public Health, School of Health, Golestan University of Medical Sciences, Gorgan, Iran.
Abdurrahman CharkaziEnvironmental Health Research Center, Department of Public Health, School of Health, Golestan University of Medical Sciences, Gorgan, Iran.
Yousef Dadban ShahamatEnvironmental Health Research Center, Department of Environmental Health Engineering, School of Health, Golestan University of Medical Sciences, Gorgan, Iran.
Zahra MehrbakhshDepartment of Biostatistics, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran.
Ali BagheriCommunicable Disease Control of Health Center, Golestan University of Medical Sciences, Gorgan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeishmaniasis occurs with an incidence of 0.5-1.5 million new cases annually, and is also endemic in 88 countries across the world.

aimPresently, we aimed to investigate the status of Cutaneous Leishmaniasis (CL) in Golestan Province in North of Iran.

methodsA retrospective survey was conducted on existed data of 6873 patients with CL who attended to Health Centers in Golestan Province during 2010 to 2017 years. Data were collected using patient sheets and online registry form of CL. Descriptive statistical methods such as mean and standard deviation, and Chi-square test were employed to report and analyze results. p-Value <0.05 was considered significant.

resultsCL cases were more common in men 3885 (56.7%) than women 2965 (43.3%) (p = 0.001). The most and least cases was reported in 2017 and 2104 as 18 and 3 CL cases, accordingly. CL was mainly happen in the November (3816 cases), December (2832 cases) months. Presently, CL gradually increases in the last three years from 2014 to 2017 years.

conclusionDecrease of exposurement, improve the nutrition and child's immunity can be more beneficial.

Indexed as

CutaneousIncidenceLeishmaniasisRegistries

Identifiers

PMID30937404
PMCPMC6430073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.